Skip to main content
. 2012 Aug 10;17(8):9573–9589. doi: 10.3390/molecules17089573

Table 1.

Effects of trachylobane-360 isolated from Xylopia langsdorffiana on organ weights. Mice were inoculated with sarcoma 180 cells (25 × 106 cells/mL, s.c.). The animals were treated for seven consecutive days, starting one day after tumor implantation.

Drug Dose (mg/kg) Thymus (mg/g body weight) Spleen (mg/g body weight) Liver (mg/g body weight) Kidney (mg/g body weight) Initial weight (g) Final weight (g)
Healthy mice
(5% Tween-80) - 3.09 ± 0.30 5.21 ± 0.24 56.33 ± 0.49 12.23 ± 0.74 32.07 ± 0.79 32.38 ± 0.62
Control-S180
(5% Tween-80) - 4.36 ± 0.50 c 6.85 ± 0.50 c 63.30 ± 1.17 10.62 ± 0.13 31.43 ± 0.99 34.54 ± 0.90
5-FU 25 2.13 ± 0.11 a 5.24 ± 0.15 a 57.52 ± 0.92 a 10.67 ± 0.59 30.27 ± 0.49 30.35 ± 0.73 a
Trachylobane-360 12.5 3.80 ± 0.31 b 7.62 ± 0.37 b,c 63.04 ± 1.60 11.39 ± 0.28 32.10 ± 0.68 33.77 ± 0.70
Trachylobane-360 25 3.41 ± 0.16 b 7.59 ± 0.36 b,c 58.75 ± 1.07 10.96 ± 0.56 29.73 ± 0.50 31.37 ± 0.53 a

Data are presented as means ± SEM for six animals. a p < 0.05, compared to control-S180, by ANOVA followed by Tukey’s test; b p < 0.05, compared to mice transplanted with S180 tumor and treated with 5-FU, by ANOVA followed by Tukey’s test; c p < 0.05, compared to healthy mice, by ANOVA followed by Tukey’s test.

HHS Vulnerability Disclosure